Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
9.57
-0.48 (-4.78%)
At close: Jun 27, 2025, 4:00 PM
9.55
-0.02 (-0.21%)
After-hours: Jun 27, 2025, 7:11 PM EDT
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $1.09 billion as of June 27, 2025. Its market cap has decreased by -65.18% in one year.
Market Cap
1.09B
Enterprise Value
433.63M
1-Year Change
-65.18%
Ranking
Category
Stock Price
$9.57
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $1.09B, an increase of 37.54%. That is a compound annual growth rate of 6.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 1.14B | -52.35% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |